Jemima Albayda

4.1k total citations
74 papers, 2.5k citations indexed

About

Jemima Albayda is a scholar working on Epidemiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Jemima Albayda has authored 74 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Epidemiology, 38 papers in Rheumatology and 17 papers in Molecular Biology. Recurrent topics in Jemima Albayda's work include Inflammatory Myopathies and Dermatomyositis (62 papers), Eosinophilic Disorders and Syndromes (28 papers) and Muscle Physiology and Disorders (17 papers). Jemima Albayda is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (62 papers), Eosinophilic Disorders and Syndromes (28 papers) and Muscle Physiology and Disorders (17 papers). Jemima Albayda collaborates with scholars based in United States, Spain and Japan. Jemima Albayda's co-authors include Lisa Christopher‐Stine, Julie J. Paik, Andrew L. Mammen, Iago Pinal‐Fernandez, Sonye K. Danoff, María Casal-Domínguez, Livia Casciola‐Rosen, Cheilonda Johnson, Eleni Tiniakou and Thomas E. Lloyd and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Neurology.

In The Last Decade

Jemima Albayda

65 papers receiving 2.5k citations

Peers

Countries citing papers authored by Jemima Albayda

Since Specialization

Citations

This map shows the geographic impact of Jemima Albayda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jemima Albayda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jemima Albayda more than expected).

Fields of papers citing papers by Jemima Albayda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jemima Albayda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jemima Albayda. The network helps show where Jemima Albayda may publish in the future.

Co-authorship network of co-authors of Jemima Albayda

This figure shows the co-authorship network connecting the top 25 collaborators of Jemima Albayda. A scholar is included among the top collaborators of Jemima Albayda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jemima Albayda. Jemima Albayda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improvement of recalcitrant multisystem disease in dermatomyositis with anifrolumab: a case series 2025 ·Lara D. Veeken ·(unknown), (unknown), Jemima Albayda, Eleni Tiniakou, Junren Kang	0
2	Imaging Modalities in Myositis 2024 ·Rheumatic Disease Clinics of North America ·Takeshi Yoshida, Jemima Albayda	2
3	The Relationship Between Anti–Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti‐Sp4 Autoantibodies, and Cancer in Anti–Transcription Intermediary Factor 1γ–Positive Dermatomyositis 2024 ·ACR Open Rheumatology ·Christopher A. Mecoli, David Fiorentino, Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Brittany L. Adler, Andrew L. Mammen, Lisa Christopher‐Stine, Antony Rosen, Livia Casciola‐Rosen	0
4	Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies 2024 ·Lara D. Veeken ·(unknown), Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Brittany L. Adler, Andrew L. Mammen, Lisa Christopher‐Stine, Christopher A. Mecoli	0
5	Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy 2024 ·Annals of the Rheumatic Diseases ·Eleni Tiniakou, (unknown), (unknown), Jemima Albayda, Brittany L. Adler, Julie J. Paik, Christopher A. Mecoli, Alison W. Rebman, Mark J. Soloski, Lisa Christopher‐Stine, Kellie N. Smith, Antony Rosen, Andrew L. Mammen, Erika Darrah	1
6	Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series 2023 ·Lara D. Veeken ·Caoilfhionn M Connolly, (unknown), Christopher A. Mecoli, Brittany L. Adler, Eleni Tiniakou, Jemima Albayda, Lisa Christopher‐Stine, Julie J. Paik	0
7	Correlation of muscle ultrasound with clinical and pathological findings in idiopathic inflammatory myopathies 2023 ·Muscle & Nerve ·Takeshi Yoshida, Hiroki Yamazaki, (unknown), Naoko Takamatsu, (unknown), Yusuke Osaki, Yoshinori Taniguchi, Taiki Nozaki, Yoshitaka Kumon, Jemima Albayda, Ichizo Nishino, Yuishin Izumi	6
8	Association of Anti‐CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti–Transcriptional Intermediary Factor 1γ–Positive Dermatomyositis 2023 ·Arthritis & Rheumatology ·David Fiorentino, Christopher A. Mecoli, Takeru Igusa, Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Brittany L. Adler, Andrew L. Mammen, Ami A. Shah, Antony Rosen, Lisa Christopher‐Stine, Livia Casciola‐Rosen	21
9	Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients 2023 ·Arthritis Care & Research ·Christopher A. Mecoli, Brant Chee, (unknown), (unknown), Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Brittany L. Adler, (unknown), Andrew L. Mammen, Elizabeth A. Platz, Livia Casciola‐Rosen, Lisa Christopher‐Stine, Ami A. Shah	2
10	Snap, Crackle, and Pop: From a Painful Finger to Progressive Dyspnea to Popping Neck Pain 2022 ·The American Journal of Medicine ·Lauren Smith, Ana‐Maria Orbai, (unknown), Jemima Albayda, (unknown), Tianshi David Wu, Noah Lechtzin, Allan C. Gelber	0
11	Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population 2022 ·Arthritis & Rheumatology ·Christopher A. Mecoli, Takeru Igusa, (unknown), (unknown), Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Brittany L. Adler, Carrie Richardson, (unknown), Sonye K. Danoff, Andrew L. Mammen, Elizabeth A. Platz, Antony Rosen, Lisa Christopher‐Stine, Livia Casciola‐Rosen, Ami A. Shah	21
12	Anti-MDA5-positive dermatomyositis and remission in a single referral centre population 2022 ·Clinical and Experimental Rheumatology ·Eleni Tiniakou, Christopher A. Mecoli, William G. Kelly, Jemima Albayda, Julie J. Paik, (unknown), Cheng Ting Lin, Andrew L. Mammen, Sonye K. Danoff, Livia Casciola‐Rosen, Lisa Christopher‐Stine	10
13	Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis‐Specific Autoantibodies 2021 ·Arthritis & Rheumatology ·María Casal-Domínguez, Iago Pinal‐Fernandez, Katherine Pak, Wilson Huang, Albert Selva-O’Callaghan, Jemima Albayda, Livia Casciola‐Rosen, Julie J. Paik, Eleni Tiniakou, Christopher A. Mecoli, Thomas E. Lloyd, Sonye K. Danoff, Lisa Christopher‐Stine, Andrew L. Mammen	29
14	A North American Cohort of Anti‐SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases 2021 ·ACR Open Rheumatology ·Jemima Albayda, Christopher A. Mecoli, Livia Casciola‐Rosen, Sonye K. Danoff, Cheng Ting Lin, David Hines, Laura Gutierrez‐Alamillo, Julie J. Paik, Eleni Tiniakou, Andrew L. Mammen, Lisa Christopher‐Stine	32
15	Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis 2021 ·Arthritis & Rheumatology ·Iago Pinal‐Fernandez, Katherine Pak, Albert Gil‐Vila, (unknown), (unknown), María Casal-Domínguez, Assia Derfoul, (unknown), Albert Selva-O’Callaghan, (unknown), Livia Casciola‐Rosen, Jemima Albayda, Julie J. Paik, Eleni Tiniakou, Sonye K. Danoff, Thomas E. Lloyd, Frederick W. Miller, Lisa G. Rider, Lisa Christopher‐Stine, Andrew L. Mammen, (unknown)	6
16	Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten Patients 2020 ·Arthritis & Rheumatology ·Julie J. Paik, Livia Casciola‐Rosen, Joseph Shin, Jemima Albayda, Eleni Tiniakou, Doris G. Leung, Laura Gutierrez‐Alamillo, Jamie Perin, Liliana Florea, Corina Antonescu, Sherry Leung, (unknown), Andrew Koenig, Lisa Christopher‐Stine	111
17	The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease 2019 ·Respiratory Medicine ·(unknown), Iago Pinal‐Fernandez, Kevin J. Psoter, Julie J. Paik, Jemima Albayda, Christopher A. Mecoli, Eleni Tiniakou, Andrew L. Mammen, Lisa Christopher‐Stine, Sonye K. Danoff, Cheilonda Johnson	15
18	Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease 2019 ·Respiratory Medicine ·J.A. Huapaya, Robert W. Hallowell, Leann Silhan, Iago Pinal‐Fernandez, María Casal-Domínguez, Cheilonda Johnson, Jemima Albayda, Julie J. Paik, Cheng Ting Lin, (unknown), Andrew L. Mammen, Lisa Christopher‐Stine, Sonye K. Danoff	34
19	Automated diagnosis of myositis from muscle ultrasound: Exploring the use of machine learning and deep learning methods 2017 ·PLoS ONE ·Philippe Burlina, Seth Billings, Neil Joshi, Jemima Albayda	107
20	Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab 2016 ·Annals of the Rheumatic Diseases ·Laura C. Cappelli, (unknown), Alan N. Baer, Jemima Albayda, Rebecca Manno, Uzma Haque, Evan J. Lipson, Karen B. Bleich, Ami A. Shah, Jarushka Naidoo, Julie R. Brahmer, Dung T. Le, Clifton O. Bingham	277

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact